← Leaderboards
Feyruz Virgilia Rassool
University Of Maryland Baltimore
$1,878,287
Attributed
$3,707,978
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $590.7K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,707,978 · 4
By mechanism
R01$2,744,536 · 1
R21$736,727 · 2
P30$226,715 · 1
Top collaborators
- Stephen B Baylin5 shared
- Hariharan Easwaran5 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- David Joseph Weber$22,294,951
- Xiaoxuan Fan$508,997
- Nicholas P Ambulos$3,250,144
- Rao P Gullapalli$9,032,776
- Soren M Bentzen$613,579
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMolecularResponseChromatinRecruitFundingPathway InteractionsPharmaceutical PreparationsPositioning AttributeMemberClinicDna RepairSmall Hairpin RnaCancer CellProteinsSiteTranslatingMutateNovel TherapeuticsIn VitroDna DamageDna Repair GeneMalignant NeoplasmsTumor
Grant awards (12)
Experimental Therapeutics Program$128,751
P30 · FY2025 · CA · contact PI
Experimental Therapeutics Program$48,982
P30 · FY2024 · CA · contact PI
DNA Methyltransferase Gene Expression in Colon Cancer$541,697
R01 · FY2023 · ES
Experimental Therapeutics Program$48,982
P30 · FY2023 · CA · contact PI
DNA Methyltransferase Gene Expression in Colon Cancer$541,697
R01 · FY2022 · ES
DNA Methyltransferase Gene Expression in Colon Cancer$541,697
R01 · FY2021 · ES
DNA Methyltransferase Gene Expression in Colon Cancer$541,697
R01 · FY2020 · ES
DNA Methyltransferase Gene Expression in Colon Cancer$577,748
R01 · FY2019 · ES
Mechanism-based approach to combine histone deacetylase inhibitors with PARP inhibitors for therapy in AML$168,019
R21 · FY2018 · CA · contact PI
Mechanism-based approach to combine histone deacetylase inhibitors with PARP inhibitors for therapy in AML$201,459
R21 · FY2017 · CA · contact PI
Mechanisms for sensitivity to PARP inhibitors in cancers involving ALT NHEJ$166,931
R21 · FY2016 · CA · contact PI
Mechanisms for sensitivity to PARP inhibitors in cancers involving ALT NHEJ$200,318
R21 · FY2015 · CA · contact PI